Search clinical trials for: Angiotensin converting enzyme inhibitor (Lisinopril)

Total 47094 results

Chinese University of Hong Kong

Terminated

Drug to Prevent Pneumonia in the Tube Fed

Pneumonia | Neurological Dysphagia

Hong Kong
University of Wisconsin, Madison

Completed

Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease

Cardiovascular Disease | Chronic Kidney Disease

United States
Turkish Nephrology Association

Completed

Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients

Disorders Associated With Peritoneal Dialysis
University Hospital, Clermont-Ferrand
Servier; LivaNova

Completed

Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients? (HF 80)

Heart Failure

France
University Ghent

Completed

Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension (Lisi-ped)

Primary Hypertension | Secondary Hypertension

Belgium
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions

Healthy

United States
Novartis

Completed

VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria

Hypertension

Switzerland, Germany
Novartis

Terminated

Antialbuminuric Effects of Valsartan and Lisinopril

Hypertension | Early Diabetic Nephropathy

Switzerland
Par Pharmaceutical, Inc.
PharmaKinetics Laboratories Inc.

Completed

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Healthy

United States
The Affiliated Hospital of Qingdao University

Completed

Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects

Therapeutic Equivalency

China
University of Rochester
Medical College of Wisconsin

Recruiting

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

Prostate Cancer | Radiation Toxicity | Urinary Complication

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Hyperoxaluria
Hoffmann-La Roche

Completed

A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril

Diabetes Mellitus Type 2

United States
Novartis

Completed

Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes

Hypertension

Germany
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions

Healthy

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

Fed

India
Shanghai Municipal Health Bureau

Unknown

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3 (FLIP)

Proteinuria | Angiotensin II Type 1 Receptor Blockers | Chronic Kidney Insufficiency | Angiotensin-Converting Enzyme Inhibitors

China
Vanderbilt University Medical Center

Completed

Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children

Congenital Heart Disease

United States
US Department of Veterans Affairs

Terminated

VA NEPHRON-D: Diabetes iN Nephropathy Study (VA NEPHRON-D)

Type 2 Diabetes | Nephropathy | Kidney Disease

United States, Puerto Rico
Cooperative International Neuromuscular Research...
United States Department of Defense

Completed

Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies

Duchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb Girdle Muscular Dystrophy

United States, Japan, Canada
Novo Nordisk A/S

Completed

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

Healthy | Diabetes

Germany
Sandoz

Completed

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions

Hypertension
National Heart, Lung, and Blood Institute (NHLBI)

Completed

ACE Inhibition and Novel Cardiovascular Risk Factors

Heart Diseases | Cardiovascular Diseases | Hypertension
Chiang Mai University

Unknown

Effects of Renin-Angiotensin System Inhibitors in Peritoneal Dialysis Patients

Peritoneal Dialysis

Thailand
Medical Practice Prof D. Ivanov

Completed

ARB, ACEi, DRi Effects on COVID-19 Course Disease (BIRCOV)

COVID-19 | Hypertension

Ukraine
Mayo Clinic
National Cancer Institute (NCI)

Completed

Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

Small Cell Lung Cancer | Non-small Cell Lung Cancer | Dyspnea

United States
Imperial College London
Medical Research Council

Completed

Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Memorial Health University Medical Center

Unknown

The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

Hypertension, Resistant to Conventional Therapy

United States
GlaxoSmithKline

Completed

Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

Hypertension

United States
Par Pharmaceutical, Inc.
PharmaKinetics Laboratories Inc.

Completed

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

To Determine Bioequivalence Under Fed Conditions

United States
GlaxoSmithKline

Completed

Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.

Hypertension

United States
Sandoz

Completed

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed

Hypertension
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Brazil
Soroka University Medical Center

Completed

Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy

Radiographic Contrast Agent Nephropathy
Brigham and Women's Hospital

Completed

The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study (RAAS-PARC)

Hyperparathyroidism

United States
Uptal Patel
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant (PTN_LISINO)

Hypertension

United States
Eastern Virginia Medical School

Withdrawn

Lisinopril for Renal Protection in Postpartum Preeclamptic Women

Preeclampsia | Microalbuminuria

United States
University of Sao Paulo General Hospital

Completed

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure (NEPRIExTol)

Heart Failure | Body Composition | Vasodilation | Muscle Strength | Exercise Tolerance

Brazil
Bright Future Pharmaceuticals Factory O/B Bright...
Chinese University of Hong Kong

Unknown

Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations

Healthy
Northwell Health
Lupus Research Alliance

Recruiting

Centrally Acting ACE Inhibition in SLE

Systemic Lupus Erythematosus

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Steno Diabetes Center Copenhagen

Completed

Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

Diabetic Nephropathy | Diabetes Mellitus, Type I

Denmark
Sohag University

Not yet recruiting

Serum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous Patients

Systemic Lupus Erythematosus

Egypt
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Monia Lorini
Istituto Di Ricerche Farmacologiche Mario Negri

Unknown

ACE-inhibitors in Extracapillary Glomerulonephritis (EXTRA)

Extracapillary Glomerulonephritis

Italy
University of California, San Francisco
amfAR, The Foundation for AIDS Research

Completed

ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study

HIV

United States
University Hospital, Basel, Switzerland

Completed

RAS-Peptide-Profile Study in Healthy Male Subjects (RAS)

RAS Peptide Profile in Healthy Volunteers

Switzerland
D'Or Institute for Research and Education
Brazilian Clinical Research Institute

Unknown

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 (BRACE-CORONA)

COVID-19 | Corona Virus Infection

Brazil
Newcastle-upon-Tyne Hospitals NHS Trust
Northumbria Healthcare NHS Foundation Trust; North East Ambulance Service NHS...

Completed

Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST)

Stroke

United Kingdom

Search clinical trials for: Angiotensin converting enzyme inhibitor (Lisinopril)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations